West Pharma (WST) Tops Q1 EPS by 19c, Revenues Beat; Raises FY20 EPS Guidance Above Consensus, FY20 Revenue Outlook Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to West Pharma (WST) Tops Q1 EPS by 19c, Revenues Beat; Raises FY20 EPS Guidance Above Consensus, FY20 Revenue Outlook Above Consensus

West Announces First-Quarter 2020 Results

April 23, 2020 6:00 AM EDT

EXTON, Pa., April 23, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2020 and updated full-year 2020 financial guidance.

First-Quarter 2020 Summary (comparisons to prior-year period)

Net sales of $491.5 million grew 10.8%; organic... More